Skip to main content

Table 3 Risk factors for 30 day mortality in patients treated with BLICs

From: Comparison of therapy with β-lactam/β-lactamase inhibitor combinations or carbapenems for bacteraemia of nonurinary source caused by ESBL-producing Escherichia coli or Klebsiella pneumoniae

  Univariate analysis Multivariate analysis Univariate analysis Multivariate analysis
Variables P HR (95%CI), P Adjusted P Adjusted HR (95%CI), P
Leukemia 0.018 8.82 (1.79–43.33), 0.007 0.015 7.79 (1.48–40.86), 0.015
SOFA score 0.037 1.21 (0.98–1.50), 0.074 0.150 1.28 (0.93–1.77), 0.132
aCCI 0.033 1.22 (1.03–1.45), 0.019 0.280  
Pitt bacteremia score 0.300   0.242  
Age 0.713   0.959  
Immune-compromise 0.981   0.659